Literature DB >> 301545

Lectin-driven maturation of cytotoxic effector cells: the nature of effector memory.

A K Chakravarty, W R Clark.   

Abstract

In an attempt to define further the activation of effector T-cell function with concanavalin A (Con A), we examined the ability of Con A to generate effector memory in mouse lymph node cells in vitro. In the course of these studies, it became necessary to define parameters by which memory could be defined. These parameters include length of time of exposure to signal required to generate full cytotoxic function; time of onset and kinetics of blast cell formation; requirement for DNA synthesis; sensitivity to the drug 5'-bromodeoxyuridine; and kinetics of the cytotoxic response to alloantigen. By these criteria, mouse lymph node cells exposed 12 days previously to Con A behave qualitatively differently from unprimed mouse lymphocytes. We found that the time of onset and kinetics of DNA synthesis could not be used to distinguish primary and secondary cytotoxic responses. We propose that the parameters defined in these stidues can be applied generally in determining whether a given cytotoxic response involves primed (memory) or unprimed cells.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 301545      PMCID: PMC2180742          DOI: 10.1084/jem.146.1.230

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  Secondary cytotoxic allograft responses in vitro. II. Differentiation of memory T cells into cytotoxic T lymphocytes in the absence of cell proliferation.

Authors:  H Wagner; M Röllinghoff
Journal:  Eur J Immunol       Date:  1976-01       Impact factor: 5.532

2.  Immunologically specific cytolytic activity induced in long-term mixed leukocyte culture cells by concanavalin A.

Authors:  D Tartof; F W Fitch
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

Review 3.  Toward molecular mechanisms of developmental processes.

Authors:  W J Rutter; R L Pictet; P W Morris
Journal:  Annu Rev Biochem       Date:  1973       Impact factor: 23.643

4.  Lymphocyte-mediated cytotoxicity against tumor cells. I. Con A activated cytotoxic effector cells exhibit immunological specificity.

Authors:  J D Waterfield; E M Waterfield; G Möller
Journal:  Cell Immunol       Date:  1975-06       Impact factor: 4.868

5.  H-2 antigen-specific cytotoxic T cells induced by concanavalin A: estimation of their relative frequency.

Authors:  M J Bevan; R E Langman; M Cohn
Journal:  Eur J Immunol       Date:  1976-03       Impact factor: 5.532

6.  Hydroxyurea and cell-cycle kinetics of cultured antibody-forming cells.

Authors:  B N Jaroslow; L Oritz-Oritz
Journal:  Cell Immunol       Date:  1971-04       Impact factor: 4.868

7.  Activation of cytotoxic function in T lymphocytes.

Authors:  D Heininger; M Touton; A K Chakravarty; W R Clark
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

8.  Generation of cytotoxic T lymphocytes in vitro. IV. Functional activation of memory cells in the absence of DNA synthesis.

Authors:  H R MacDonald; B Sordat; J C Cerottini; K T Brunner
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

9.  Concanavalin A-mediated activation of antigen-primed lymphocytes into secondary cytotoxic lymphocytes.

Authors:  B Bonavida
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

10.  The requirement for DNA synthesis and gene expression in the generation of cytotoxicity in vitro.

Authors:  J Nedrud; M Touton; W R Clark
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

View more
  2 in total

1.  A comparison between LCM virus-specific secondary cytotoxic T lymphocytes generated by Con A and by the homologous antigen.

Authors:  O Marker; G T Andersen
Journal:  Immunology       Date:  1979-10       Impact factor: 7.397

2.  Inhibition of tumor-induced angiogenesis and of tumor growth by activated lymphocytes.

Authors:  A K Chakravarty; U K Maitra
Journal:  Experientia       Date:  1983-05-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.